Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence

• Published in: Dermatologic therapy Vol. 35; no. 12; pp. e15903 - n/a
• Main Authors: Bravo, Bruna, Correia, Priscila, Gonçalves Junior, José Euzébio, Sant'Anna, Beatriz, Kerob, Delphine
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.12.2022
• Subjects: Adult; Botulinum Toxins, Type A; cosmeceutical; Cosmeceuticals - adverse effects; Cosmetic Techniques - adverse effects; Dermal Fillers - adverse effects; dermatology; Humans; Hyaluronic Acid; Randomized Controlled Trials as Topic; Rejuvenation; Review; skin; Skin Aging; topical application; skin; dermatology; cosmeceutical; topical application; hyaluronic acid
• ISSN: 1396-0296; 1529-8019; 1529-8019
• DOI: 10.1111/dth.15903

Skin aging goes beyond a chronological process and also results from extrinsic factors referred to as the exposome. Hyaluronic acid (HA) is an important component of the extracellular matrix, with loss starting at 25 years old. While many studies of HA concern topical use, few literature reviews only address the use of topical HA in dermatology. This review describes the different characteristics of HA‐containing cosmeceuticals, with a focus on skin aging and the impact of exposome factors on HA synthesis and degradation. A review was performed using the terms HA, hyaluronan, topical, dermatology, cosmetic, aging treatment, exposome, and cosmeceuticals. Results are also presented from a recent randomized controlled trial (RCT), which investigated the additional benefit of using a HA epidermic filler (HA‐filler serum) combined with Botulinum toxin type A (BoNTA) to treat signs of skin aging. Subjects were randomized to two groups: HA‐filler serum starting 24 h after the BoNTA injection then twice daily for 24 weeks, or the control group, which received BoNTA. HA is a key ingredient used in cosmeceuticals for its hydration/antiaging properties (hygroscopic, rheological, and viscoelastic). Several clinical studies indicate that HA is both well tolerated and effective, adjuvant to both post‐surgical and facial rejuvenation procedures. In the RCT, one of few studies to combine BoNTA and HA with a 6‐month follow‐up, the HA‐filler serum lengthened the duration of BoNTA's effect in reducing wrinkles. Numerous studies support HA‐based cosmeceuticals as a noninvasive, effective solution for improving skin hydration and rejuvenation.